NCT05014776 2026-04-28Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic CancerSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2 Completed17 enrolled 8 charts